Cited 24 times in
Clinical features and prognostic relevance of ovarian involvement in non-Hodgkin's lymphoma: A Consortium for Improving Survival of Lymphoma (CISL) report.
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김진석 | - |
dc.date.accessioned | 2015-04-23T17:15:13Z | - |
dc.date.available | 2015-04-23T17:15:13Z | - |
dc.date.issued | 2010 | - |
dc.identifier.issn | 0145-2126 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/102112 | - |
dc.description.abstract | Fourteen patients had primary ovarian lymphoma, while eighteen patients had secondary ovarian involvement. There was no significant difference in survival rates between primary and secondary involvement with diffuse large B-cell lymphoma (DLBCL), the most common subtype. The 5-year overall survivals of primary and secondary involvement with DLBCL were 70.0% and 59.3%, respectively. The localized bilateral ovarian involvement showed poorer survival compared to stage III/IV patients with secondary ovarian involvement. Treatment outcomes of secondary ovarian involvement in non-Hodgkin's lymphoma were comparable to those of primary ovarian involvement, suggesting that ovarian involvement does not necessarily predict a worse prognosis for NHL patients. | - |
dc.description.statementOfResponsibility | open | - |
dc.format.extent | 1175~1179 | - |
dc.relation.isPartOf | LEUKEMIA RESEARCH | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Adolescent | - |
dc.subject.MESH | Adult | - |
dc.subject.MESH | Aged | - |
dc.subject.MESH | Aged, 80 and over | - |
dc.subject.MESH | Antineoplastic Combined Chemotherapy Protocols/therapeutic use | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Lymphoma, Non-Hodgkin/drug therapy | - |
dc.subject.MESH | Lymphoma, Non-Hodgkin/pathology* | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Middle Aged | - |
dc.subject.MESH | Ovarian Neoplasms/pathology | - |
dc.subject.MESH | Ovarian Neoplasms/secondary* | - |
dc.subject.MESH | Prognosis | - |
dc.subject.MESH | Recurrence | - |
dc.subject.MESH | Survival Rate | - |
dc.subject.MESH | Treatment Outcome | - |
dc.subject.MESH | Young Adult | - |
dc.title | Clinical features and prognostic relevance of ovarian involvement in non-Hodgkin's lymphoma: A Consortium for Improving Survival of Lymphoma (CISL) report. | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학) | - |
dc.contributor.googleauthor | Jina Yun | - |
dc.contributor.googleauthor | Seok Jin Kim | - |
dc.contributor.googleauthor | Jong Ho Won | - |
dc.contributor.googleauthor | Chul Won Choi | - |
dc.contributor.googleauthor | Hyeon Seok Eom | - |
dc.contributor.googleauthor | Jin Seok Kim | - |
dc.contributor.googleauthor | Min Kyoung Kim | - |
dc.contributor.googleauthor | Jae-Yong Kwak | - |
dc.contributor.googleauthor | Won Seog Kim | - |
dc.contributor.googleauthor | Cheolwon Suh | - |
dc.identifier.doi | 10.1016/j.leukres.2010.02.010 | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A01017 | - |
dc.relation.journalcode | J02166 | - |
dc.identifier.eissn | 1873-5835 | - |
dc.identifier.pmid | 20206997 | - |
dc.identifier.url | http://www.sciencedirect.com/science/article/pii/S0145212610000901 | - |
dc.contributor.alternativeName | Kim, Jin Seok | - |
dc.contributor.affiliatedAuthor | Kim, Jin Seok | - |
dc.citation.volume | 34 | - |
dc.citation.number | 9 | - |
dc.citation.startPage | 1175 | - |
dc.citation.endPage | 1179 | - |
dc.identifier.bibliographicCitation | LEUKEMIA RESEARCH, Vol.34(9) : 1175-1179, 2010 | - |
dc.identifier.rimsid | 49553 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.